Put Options

7 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$163.64 - $210.12 $360,007 - $462,264
2,200 Added 51.16%
6,500 $1.26 Million
Q2 2024

Aug 14, 2024

SELL
$172.27 - $223.95 $482,356 - $627,060
-2,800 Reduced 39.44%
4,300 $773,000
Q1 2024

May 15, 2024

BUY
$220.09 - $273.15 $66,027 - $81,945
300 Added 4.41%
7,100 $1.58 Million
Q4 2023

Feb 14, 2024

SELL
$181.44 - $260.22 $3.86 Million - $5.54 Million
-21,300 Reduced 75.8%
6,800 $1.71 Million
Q3 2023

Nov 14, 2023

BUY
$240.69 - $338.77 $5.51 Million - $7.76 Million
22,900 Added 440.38%
28,100 $6.8 Million
Q2 2023

Aug 14, 2023

BUY
$271.54 - $344.06 $1.36 Million - $1.72 Million
5,000 Added 2500.0%
5,200 $1.79 Million
Q1 2023

May 15, 2023

BUY
$220.43 - $278.69 $44,086 - $55,738
200 New
200 $55,000

Others Institutions Holding PEN

About Penumbra Inc


  • Ticker PEN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,888,400
  • Market Cap $9.37B
  • Description
  • Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...
More about PEN
Track This Portfolio

Track Walleye Capital LLC Portfolio

Follow Walleye Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Capital LLC with notifications on news.